TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Actelion Pharmaceuticals Sverige AB
Closing information (x1000 EUR)
Closing information | 2018/12 | 2017/12 | 2016/12 |
Turnover | 25,205 | 25,363 | 23,414 |
Financial expenses | 205 | 317 | 4 |
Earnings before taxes | 1,029 | 1,684 | 1,057 |
EBITDA | 1,023 | 1,898 | 632 |
Total assets | 17,944 | 16,379 | 14,331 |
Current assets | 17,919 | 16,311 | 14,237 |
Current liabilities | 12,746 | 11,400 | 10,374 |
Equity capital | 5,198 | 4,979 | 3,653 |
- share capital | 97 | 102 | 105 |
Employees (average) | 29 | 28 | 29 |
Financial ratios
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Solvency | 29.0% | 30.4% | 25.5% |
Turnover per employee | 869 | 906 | 807 |
Profit as a percentage of turnover | 4.1% | 6.6% | 4.5% |
Return on assets (ROA) | 6.9% | 12.2% | 7.4% |
Current ratio | 140.6% | 143.1% | 137.2% |
Return on equity (ROE) | 19.8% | 33.8% | 28.9% |
Change turnover | 893 | 2,622 | 828 |
Change turnover % | 4% | 12% | 4% |
Chg. No. of employees | 1 | -1 | 1 |
Chg. No. of employees % | 4% | -3% | 4% |
Total value of public sale
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.